Screener
Sarepta Therapeutics, Inc. SRPT Compensation and benefits
Compensation and benefits at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
| Line item | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|
| Cash flows from operating activities: | ||
| Net income (loss) | $326,069 | $(250,616) |
| Adjustments to reconcile net income (loss) to net cash used in operating activities | ||
| Stock-based compensation | 53,871 | 78,453 |
| Depreciation and amortization | 21,003 | 20,818 |
| Non-cash interest expense | 19,006 | 2,602 |
| Non‑cash inventory write‑downs for obsolescence | 11,599 | — |
| Reduction in the carrying amounts of the right of use assets | 6,322 | 7,956 |
Item 1. Financial Statements
FAQ
- What is Sarepta Therapeutics, Inc.'s compensation and benefits?
- Sarepta Therapeutics, Inc. (SRPT) reported compensation and benefits of $24.47M in Q2 2026.
- How has Sarepta Therapeutics, Inc.'s compensation and benefits changed year-over-year?
- Sarepta Therapeutics, Inc.'s compensation and benefits decreased by 33.9% year-over-year, from $37M to $24.47M.
- What does compensation and benefits mean?
- Total employee-related costs including salaries, wages, bonuses, commissions, stock-based compensation, health insurance, retirement contributions, and payroll taxes.
Ask your AI about Sarepta Therapeutics, Inc.'s compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude